Having trouble accessing articles? Reset your cache.

FDA guidance seeks to better integrate patient priorities into drug development

Patient-centered drug development must start with an understanding of what patients feel is important about their condition and the attributes they’d like to see in medicines. A draft guidance FDA released Monday on

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE